[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dialysis Equipment and Services Market Canvasses in In-Demand Report by Kalorama Information

22 May 2013 • by Natalie Aster

Diagnosis is based on results from blood tests and urinalysis, and on the patient's medical history and signs and symptoms. Blood test results that show high levels of creatinine indicate renal ischemia, atheroembolism, or exposure to radio contrast dye. Severe anemia (a low red blood count) may indicate TTP-HUS. Hyperkalemia (a high level of potassium), hyperphosphatemia (a high level of phosphorous), and hypocalcemia (a low level of calcium) occur in rhabdomyolysis.

Urinalysis shows many red and white cells in the urine, and the level of sodium may be high. Proteinuria is a common finding. Mild proteinuria suggests that failure is caused by injured tubules. Moderate proteinuria indicates glomerular injury. Heavy proteinuria occurs in allergic interstitial nephritis.

According to the report “The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada )” by Kalorama Information, renal biopsy is performed when laboratory test results suggest more than one possible cause of intrinsic ARF. Ultrasound rules out postrenal obstruction (i.e., obstruction in the bladder or urethra) as the cause of symptoms.

Report Details:

The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada)
Published: April, 2013
Pages: 244
Price: US$ 3,995.00

The goal of treatment for intrinsic ARF is to resolve the underlying cause and its complications. In nephrotoxic ARF, the toxins are eliminated. In ischemic ARF, adequate blood flow to the kidneys is restored. Acute glomerulonephritis and vasculitis are treated with glucocorticoids and plasmapheresis (plasma exchange). In allergic interstitial nephritis, the drug causing the condition is discontinued and glucocortoids are given. Malignant hypertension is treated with ACE inhibitors to control blood pressure.

More information can be found in the report “The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada)” by Kalorama Information.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com

Analytics & News

Weekly Digest